ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,295 | -44.6% | 143,935 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,380,087 | +3.2% | 144,815 | +19.2% | 0.00% | -50.0% |
| Q1 2023 | $1,336,885 | -28.1% | 121,535 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $1,860,648 | -25.6% | 125,821 | -3.8% | 0.00% | -50.0% |
| Q3 2022 | $2,501,000 | +5.0% | 130,724 | +17.0% | 0.00% | +33.3% |
| Q2 2022 | $2,383,000 | +34.4% | 111,757 | +21.5% | 0.00% | +50.0% |
| Q1 2022 | $1,773,000 | +118.9% | 91,988 | +166.5% | 0.00% | +100.0% |
| Q4 2021 | $810,000 | +217.6% | 34,523 | +283.2% | 0.00% | – |
| Q4 2020 | $255,000 | – | 9,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |